Seattle Genetics, Inc. Appoints John A. Orwin To Board Of Directors
Published: Jan 13, 2014
Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that John A. Orwin has been appointed to the company’s Board of Directors. Mr. Orwin is a biotechnology and pharmaceutical industry veteran with nearly 25 years of experience, including senior leadership positions in many commercial oncology organizations. He currently serves as Chief Executive Officer of Relypsa, a clinical-stage pharmaceutical company.
Help employers find you! Check out all the jobs and post your resume.